Literature DB >> 10699167

A nuclear receptor to prevent colon cancer.

G D Wu1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10699167     DOI: 10.1056/NEJM200003023420909

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

1.  Adaptive elastic-net sparse principal component analysis for pathway association testing.

Authors:  Xi Chen
Journal:  Stat Appl Genet Mol Biol       Date:  2011-10-24

Review 2.  Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.

Authors:  Annaswamy Raji; Jorge Plutzky
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

3.  Expression of peroxisome proliferator-activated receptor-gamma in colon cancer: correlation with histopathological parameters, cell cycle-related molecules, and patients' survival.

Authors:  Stamatios Theocharis; Costas Giaginis; Aikaterini Parasi; Alexandra Margeli; John Kakisis; Emmanuel Agapitos; Gregorios Kouraklis
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

4.  PPARgamma pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells.

Authors:  Ming-Yi Li; Hua Deng; Jia-Ming Zhao; Dong Dai; Xiao-Yu Tan
Journal:  World J Gastroenterol       Date:  2003-06       Impact factor: 5.742

5.  Down-regulation of PGE2 by physiologic levels of celecoxib is not sufficient to induce apoptosis or inhibit cell proliferation in human colon carcinoma cell lines.

Authors:  Shahar Lev-Ari; Dina Kazanov; Eliezer Liberman; Rami Ben-Yosef; Nadir Arber
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

6.  Peroxisome proliferator-activated receptors in diabetic nephropathy.

Authors:  Shinji Kume; Takashi Uzu; Keiji Isshiki; Daisuke Koya
Journal:  PPAR Res       Date:  2009-03-04       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.